LON:AZN

AstraZeneca Share Forecast, Price & News

GBX 8,337.02

+274.02 (+3.40 %)

(As of 09/20/2021 04:40 PM ET)

Add

Compare

Today's Range

8,150

▼

8,559

50-Day Range

8,063

▼

8,762

52-Week Range

6,499.80

▼

8,848

Volume4.03 million shs

Average Volume2.31 million shs

Market Capitalization£129.15 billion

P/E Ratio39.89

Dividend Yield2.51%

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.

About AstraZeneca

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company's marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; AliveCor, Inc. to develop non-invasive potassium monitoring solutions; Massachusetts General Hospital to accelerate digital health solutions; Sanguina on smartphone application study for hemoglobin management in patients with anemia of chronic kidney disease; Alchemab to enhance prostate cancer research; and Proteros biostructures GmbH to discover and develop novel small molecules for the treatment of various types of cancer. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca Touts Longest Survival Update In Lung Cancer Setting With Imfinzi/Chemo Data - Benzinga - Benzinga
September 20, 2021 | benzinga.com

Citigroup Reiterates Buy Rating for AstraZeneca (LON:AZN)
September 20, 2021 | americanbankingnews.com

Credit Suisse Group Analysts Give AstraZeneca (LON:AZN) a GBX 9,000 Price Target
September 20, 2021 | americanbankingnews.com

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated robust and durable tumor response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer
September 18, 2021 | finance.yahoo.com

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
September 18, 2021 | finance.yahoo.com

Panama to hand out AstraZeneca vaccines to visitors in tourism push - Reuters
September 17, 2021 | reuters.com

Morgan Stanley Reiterates "£100" Price Target for AstraZeneca (LON:AZN)
September 17, 2021 | americanbankingnews.com

Pfizer, AstraZeneca to set up clinical research centers in Saudi Arabia - Reuters - Seeking Alpha
September 15, 2021 | seekingalpha.com

JPMorgan Chase & Co. Analysts Give AstraZeneca (LON:AZN) a £100 Price Target
September 15, 2021 | americanbankingnews.com

UBS Group Reiterates GBX 9,200 Price Target for AstraZeneca (LON:AZN)
September 15, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolLON:AZN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.astrazeneca.com
Phone+44-20-73045000
Employees76,100
Year FoundedN/A

Sales & Book Value

Annual Sales£29.53 billion
Price / Sales4.37
Cash FlowGBX 1,191.21 per share
Price / Cash Flow7.00
Book ValueGBX 1,194.80 per share
Price / Book6.98

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares1,549,129,984
Market Cap£129.15 billion
Next Earnings Date11/12/2021 (Estimated)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

1.86 out of 5 stars

3.4 Analyst's Opinion

Consensus Rating
AstraZeneca has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 12 buy ratings, no hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 9,460, AstraZeneca has a forecasted upside of 13.5% from its current price of GBX 8,337.02.
Amount of Analyst Coverage
AstraZeneca has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.3 Community Rank

Outperform Votes
AstraZeneca has received 1,705 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AstraZeneca has received 921 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AstraZeneca has received 64.93% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote “Outperform” if you believe AZN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
AstraZeneca pays a meaningful dividend of 2.51%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
AstraZeneca does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of AstraZeneca is 1.37%. This payout ratio is at a healthy, sustainable level, below 75%.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AstraZeneca insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of AstraZeneca is 40.20, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.45.
Price to Earnings Ratio vs. Sector
The P/E ratio of AstraZeneca is 40.20, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.55.
Price to Book Value per Share Ratio
AstraZeneca has a P/B Ratio of 6.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

AstraZeneca (LON:AZN) Frequently Asked Questions

Is AstraZeneca a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AstraZeneca stock.
View analyst ratings for AstraZeneca or view top-rated stocks.

What stocks does MarketBeat like better than AstraZeneca?

Wall Street analysts have given AstraZeneca a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AstraZeneca wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.
View our earnings forecast for AstraZeneca.

How has AstraZeneca's stock been impacted by COVID-19 (Coronavirus)?

AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AZN stock has increased by 19.9% and is now trading at GBX 8,337.02.
View which stocks have been most impacted by COVID-19.

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a dividend on Thursday, July 29th. Investors of record on Thursday, August 12th will be given a dividend of GBX 64.80 per share on Monday, September 13th. This represents a yield of 0.78%. The ex-dividend date of this dividend is Thursday, August 12th. The official announcement can be accessed at this link.
View AstraZeneca's dividend history.

Is AstraZeneca a good dividend stock?

AstraZeneca pays an annual dividend of GBX 202 per share and currently has a dividend yield of 2.51%. The dividend payout ratio of AstraZeneca is 96.65%. Payout ratios above 75% are not desirable because they may not be sustainable.
View AstraZeneca's dividend history.

What price target have analysts set for AZN?

14 analysts have issued 1-year target prices for AstraZeneca's stock. Their forecasts range from GBX 6,950 to £105. On average, they expect AstraZeneca's share price to reach GBX 9,460 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price.
View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:

Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 62, Pay $4.39M)
Mr. Marc Dunoyer, CFO & Exec. Director (Age 69, Pay $2.45M)
Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 50)
Thomas Kudsk Larsen, Head of Investor Relations
Mr. Jefrey Pott, Exec. VP of HR & Gen. Counsel
Ms. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer
Dr. Menelas Pangalos, Exec. Vice-Pres of BioPharmaceuticals R&D
Dr. Ruud Dobber, Exec. Vice-Pres of BioPharmaceuticals Bus. Unit
Dr. Susan Mary Galbraith M.D., Ph.D., Exec. VP of Oncology R&D (Age 55)
Dr. David B. Goldstein Ph.D., Chief Adviser

Who are some of AstraZeneca's key competitors?

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer Aktiengesellschaft (BAYN), Dechra Pharmaceuticals (DPH), HUTCHMED (HCM), Vectura Group (VEC), Beximco Pharmaceuticals (BXP), Sareum (SAR), Allergy Therapeutics (AGY), ECO Animal Health Group (EAH), Trilogy International Partners (TRL), Futura Medical (FUM), Avivagen (VIV), N4 Pharma (N4P), Cathay International Holdings Limited (CTI.L) (CTI) and Antisense Therapeutics (ANP).
View all of AZN's competitors.

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN).

What is AstraZeneca's stock symbol?

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How do I buy shares of AstraZeneca?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately GBX 8,337.02.

How much money does AstraZeneca make?

AstraZeneca has a market capitalization of £129.15 billion and generates £29.53 billion in revenue each year.

How many employees does AstraZeneca have?

AstraZeneca employs 76,100 workers across the globe.

What is AstraZeneca's official website?

The official website for AstraZeneca is www.astrazeneca.com.

Where are AstraZeneca's headquarters?

AstraZeneca is headquartered at 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.

This page was last updated on 9/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here